Prognostic factors and clinical outcomes in synovial sarcoma of the extremities

Asia-Pacific Journal of Clinical Oncology

Volumn 9, Issue 1, 2013, Pages 80-85

  Wisanuyotin, Taweechok ^a   Radapat, Krisana ^a   Sirichativapee, Winai ^a   Paholpak, Permsak ^a   Kosuwon, Weerachai ^a   Sumnanoont, Chat ^a   Jeeravipoolvarn, Polasak ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Clinical outcomes; Extremities; Prognostic factors; Survival; Synovial sarcoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CHILD; CLINICAL ARTICLE; DATA BASE; DISEASE DURATION; FEMALE; HUMAN; INFANT; MALE; MEDICAL RECORD REVIEW; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYNOVIAL SARCOMA; SYNOVIAL SARCOMA OF EXTREMITY; THAILAND; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SARCOMA, SYNOVIAL; SURVIVAL RATE; TERTIARY CARE CENTERS; THAILAND; YOUNG ADULT;

EID: 84874115053     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2012.01563.x     Document Type: Article

References (27)

1. Weiss SGJ. Malignant soft tissue tumors of uncertain type. In: Weis SW, Goldblum JR (eds). Enzinger and Weiss's Soft Tissue Tumors, 4th edn. C. V. Mosby, St Louis, MO 2001; 1483-1571.
2. Siegel HJ, Sessions W, Casillas MA Jr, Said-Al-Naief N, Lander PH, Lopez-Ben R. Synovial sarcoma: clinicopathologic features, treatment, and prognosis. Orthopedics 2007; 12 : 1020-1025.
3. Brennan B, Stevens M, Kelsey A, Stiller CA. Synovial sarcoma in childhood and adolescence: a retrospective series of 77 patients registered by the Children's Cancer and Leukaemia Group between 1991 and 2006. Pediatr Blood Cancer 2010; 55 : 85-90.
4. Lewis JJ, Antonescu CR, Leung DHY etal. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000; 18 : 2087-2094.
5. Spillane AJ, A'Hern R, Judson IR etal. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000; 18 : 3794-3803.
6. Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998; 2 : 401-421.
7. Fisher C, de Bruijn DRH, Geurts van Kessel A. Synovial sarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press, Lyons 2002; 200-204.
8. Trassard M, Le Doussal V, Hacène K etal. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol 2001; 19 : 525-534.
9. ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression. Appl Immunohistochem Mol Morphol 2009; 17 : 189-195.
10. Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res 2008; 14 : 8191-8197.
11. Sakabe T, Murata H, Konishi E etal. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities. Med Sci Monit 2008; 14 : 305-310.
12. Italiano A, Penel N, Robin YM etal. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol 2009; 20 : 425-430.
13. Guadagnolo BA, Zagars GK, Ballo MT etal. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69 : 1173-1180.
14. Eilber FC, Brennan MF, Eilber FR etal. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007; 246 : 105-113.
15. Krieg AH, Hefti F, Speth BM etal. Synovial sarcomas usually metastasize after >5years: a multicenter retrospective analysis with minimum follow-up of 10years for survivors. Ann Oncol 2011; 22 : 458-467.
16. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection and mitotic activity for survival. J Clin Oncol 1996; 14 : 1201-1208.
17. Ferrari A, Gronchi A, Casanova M etal. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004; 101 : 627-634.
18. Ferrari A, Bisogno G, Alaggio R etal. Synovial sarcoma of children and adolescents: the prognostic role of axial sites. Eur J Cancer 2008; 44 : 1202-1209.
19. Bergh P, Meis-Kindblom JM, Gherlinzoni F etal. Synovial sarcoma: identification of low and high risk groups. Cancer 1999; 85 : 2596-2607.
20. Brecht IB, Ferrari A, Int-Veen C etal. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies. Pediatr Blood Cancer 2006; 46 : 11-17.
21. Paulino AC. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol 2004; 27 : 122-127.
22. Koh KH, Cho EY, Kim DW, Seo SW. Multivariate analysis of prognostic factors in synovial sarcoma. Orthopedics 2009; 32 : 824.
23. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998; 338 : 153-160.
24. Inagaki H, Nagasaka T, Otsuka T, Sugiura E, Nakashima N, Eimoto T. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma. Mod Pathol 2000; 13 : 482-488.
25. Ferrari A, Casanova M, Massimino M etal. Synovial sarcoma: report of a series of 25 consecutive children from a single institution. Med Pediatr Oncol 1999; 32 : 32-37.
26. Okcu MF, Munsell M, Treuner J etal. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol 2003; 21 : 1602-1611.
27. Sun Y, Sun B, Wang J etal. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma. Cancer Sci 2009; 100 : 1018-1025.